HBcAb positivity is an independent risk factor for HIV viral blips in HIV-HBV co-infected patients on antiretroviral therapy

被引：0
|
作者：
Malagnino, V. [1 ]
Cerva, C. [1 ]
Maffongelli, G. [2 ]
Teti, E. [2 ]
Biland, L. Foroghi [1 ]
Cesta, N. [1 ]
De Masi, M. [1 ]
Andreoni, M. [1 ]
Sarmati, L. [1 ]
机构：
[1] Policlin Tor Vergata Rome, Clin Infect Dis, Rome, Italy
[2] Tor Vergata Univ, Dept Syst Med, Rome, Italy
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P250
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Hepatitis B Virus Genotypes and Antiviral Resistance Mutations in Romanian HIV-HBV Co-Infected Patients
    Sultana, Camelia
    Casian, Mihnea
    Oprea, Cristiana
    Ianache, Irina
    Grancea, Camelia
    Chiriac, Daniela
    Ruta, Simona
    MEDICINA-LITHUANIA, 2022, 58 (04):
  • [22] Development of hepatitis B virus resistance for lamivudine in a Dutch cohort of HIV-HBV co-infected patients
    Wolters, LMM
    Niesters, HGM
    Brinkman, K
    Kroon, FP
    Richter, C
    Meenhorst, P
    de Man, RA
    JOURNAL OF HEPATOLOGY, 2001, 34 : 155 - 155
  • [23] Adefovir monotherapy not for HBV + HIV co-infected patients
    Reactions Weekly, 2005, 1066 (1) : 3 - 3
  • [24] The distribution of viral blips observed in HIV-1 infected patients treated with combination antiretroviral therapy
    Jerome K. Percus
    Ora E. Percus
    Martin Markowitz
    David D. Ho
    Michele Di Mascio
    Alan S. Perelson
    Bulletin of Mathematical Biology, 2003, 65 : 263 - 277
  • [25] The distribution of viral blips observed in HIV-1 infected patients treated with combination antiretroviral therapy
    Percus, JK
    Percus, OE
    Markowitz, M
    Ho, DD
    Di Mascio, M
    Perelson, AS
    BULLETIN OF MATHEMATICAL BIOLOGY, 2003, 65 (02) : 263 - 277
  • [26] The burden of liver disease in HIV/HBV co-infected patients accessing antiretroviral therapy in Ghana: the HEPIK study
    Appiah, L.
    Foster, G.
    Lepri, A. Cozzi
    Dusheiko, G.
    Bhagani, S.
    Chadwick, D.
    Philipps, R. O.
    Geretti, A-M
    Adinku, D. O.
    HIV MEDICINE, 2012, 13 : 43 - 43
  • [27] Hepatitis D Virus Infection among HIV-HBV Co-Infected Patients in Kermanshah, West of Iran
    Vaziri, Siavash
    Mansouri, Feizollah
    Sayad, Babak
    Afsharian, Mandana
    Janbakhsh, Afireza
    Karami, Manoochehr
    HEPATITIS MONTHLY, 2008, 8 (04) : 252 - 257
  • [28] SIGNIFICANT LIVER FIBROSIS IS AN INDEPENDENT RISK FACTOR OF RENAL IMPAIRMENT IN HIV-HBV CO-INFECTED PATIENTS TREATED WITH TENOFOVIR (TDF): RESULTS OF A 3-YEAR-COHORT STUDY
    Boyd, Anders
    Bottero, Julie
    Lascoux-combe, Caroline
    Molina, Jean-Michel
    Miailhes, Patrick
    Girard, Pierre-Marie
    Lacombe, Karine
    HEPATOLOGY, 2010, 52 (04) : 513A - 513A
  • [29] Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients
    Boyd, Anders
    Lacombe, Karine
    Lavocat, Fabien
    Maylin, Sarah
    Miailhes, Patrick
    Lascoux-Combe, Caroline
    Delaugerre, Constance
    Girard, Pierre-Marie
    Zoulim, Fabien
    JOURNAL OF HEPATOLOGY, 2016, 65 (04) : 683 - 691
  • [30] Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients
    Núñez, M
    Soriano, V
    JOURNAL OF HEPATOLOGY, 2005, 42 (03) : 290 - 292
12345